Kromatid
LONGMONT, CO · Biotechnology, Other · 36 employees
KromaTiD supports research teams in academia, large pharmaceutical, and therapeutic companies with expert scientific support and unparalleled genomics tools and services. We are your partner for biomarker discovery, genotoxicity studies, clone screening assessment of editing-associated errors, and plasmid manufacturing.
Funding history
- Series seed — $3.6M — Jul 2025
- Series seed — $3.5M — Jul 2025
- Series seed — $2.1M — Jan 2024
- Funding Round — $7.9M — Oct 2021
- Series seed — $3.6M — Jan 2017
Recent signals
- Jul 10, 2025: Raised $3.6M in Series seed
- Jul 10, 2025: Raised $3.5M in Series seed
- Jan 31, 2024: Raised $2.1M in Series seed
- Oct 15, 2021: Raised $7.9M
- Jan 26, 2017: Raised $3.6M in Series seed
See plans & pricing → Track Kromatid’s funding, hiring, and signals — with verified contacts — on Fundz.